DropCar EV/EBIT
Was ist das EV/EBIT von DropCar?
EV/EBIT von DropCar, Inc. ist N/A
Was ist die Definition von EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT von Unternehmen in Technology Sektor auf NASDAQ im Vergleich zu DropCar
Was macht DropCar?
DropCar, Inc. operates as a cloud-based vehicle support platform and mobile app. It helps consumers and automotive-related companies reduce the cost, hassles and inefficiencies of owning a car, or fleet of cars, in urban centers. The company was founded by Michael Spencer Richardson and David Brian Newman in September 2014 and is headquartered in New York, NY.
Unternehmen mit ev/ebit ähnlich DropCar
- Adamis Pharmaceuticals Corp hat EV/EBIT von N/A
- Bluewater Acquisition Corp hat EV/EBIT von N/A
- Guild Esports Plc hat EV/EBIT von N/A
- Super League Gaming hat EV/EBIT von N/A
- AF1 Capital hat EV/EBIT von N/A
- PointsBet hat EV/EBIT von N/A
- DropCar hat EV/EBIT von N/A
- Schooner Capital hat EV/EBIT von N/A
- EPE Special Opportunities hat EV/EBIT von N/A
- Sutro Biopharma Inc hat EV/EBIT von N/A
- Appili Therapeutics Inc hat EV/EBIT von N/A
- Chimeric Therapeutics Ltd hat EV/EBIT von N/A
- Quantum Cobalt hat EV/EBIT von N/A